Regencell Bioscience Holdings (Regencell Bioscience Holdings) Change In Receivables : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Change In Receivables?

Regencell Bioscience Holdings's change in receivables for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Regencell Bioscience Holdings's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

Regencell Bioscience Holdings's change in receivables for the fiscal year that ended in Jun. 2023 was $0.00 Mil. It means Regencell Bioscience Holdings's Accounts Receivable stayed the same from Jun. 2022 to Jun. 2023 .

Regencell Bioscience Holdings's Accounts Receivable for the quarter that ended in Jun. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Regencell Bioscience Holdings's liquidation value for the six months ended in Jun. 2023 was $10.93 Mil.

Regencell Bioscience Holdings Change In Receivables Historical Data

The historical data trend for Regencell Bioscience Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Change In Receivables Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Receivables

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial				-	-	-	-	-

Regencell Bioscience Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Regencell Bioscience Holdings (NAS:RGC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Regencell Bioscience Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Regencell Bioscience Holdings's accounts receivable are only considered to be worth 75% of book value:

Regencell Bioscience Holdings's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	11.565	-	0.632	+	0.75 * 0	+	0.5 * 0
=	10.93

Regencell Bioscience Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.